Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 106,891,503	$ 99,749,199
Restricted cash	0	18,005,661
Investment in marketable securities	1,127,102	1,143,095
Receivables, net	7,734,631	7,602,812
Receivables, net – related parties	48,721,325	12,514,492
Prepaid expenses and other current assets	8,388,231	5,144,303
Total current assets	172,862,792	144,159,562
Noncurrent assets
Land, property and equipment, net	12,721,082	13,814,306
Intangible assets, net	86,875,883	103,533,558
Goodwill	185,805,880	189,847,202
Loans receivable – related parties	17,500,000	15,000,000
Investments in other entities – equity method	34,876,980	21,903,524
Investment in a privately held entity that does not report net asset value per share	405,000	0
Restricted cash – long-term	745,470	745,235
Other assets	1,205,962	1,632,406
Total noncurrent assets	340,136,257	346,476,231
Total assets	512,999,049	490,635,793
Current liabilities
Lines of credit – related party	0	5,025,000
Accounts payable and accrued expenses	25,075,489	13,279,620
Provider incentives payable	0	21,500,000
Fiduciary accounts payable	1,538,598	2,017,437
Medical liabilities	33,641,701	63,972,318
Income taxes payable	11,621,861	3,198,495
Bank loan, short-term	40,257	510,391
Capital lease obligations	101,741	98,738
Total current liabilities	72,019,647	109,601,999
Noncurrent liabilities
Lines of credit - related party	13,000,000	0
Deferred tax liability	19,615,935	24,916,598
Liability for unissued equity shares	1,185,025	1,185,025
Dividend payable	0	18,000,000
Capital lease obligations, net of current portion	517,261	619,001
Total noncurrent liabilities	34,318,221	44,720,624
Total liabilities	106,337,868	154,322,623
Commitments and Contingencies (Note 14)
Mezzanine equity
Noncontrolling interest in Allied Pacific of California IPA	225,117,029	172,129,744
Shareholders' equity
Common stock, par value $0.001; 100,000,000 shares authorized, 34,578,040 and 32,304,876 shares outstanding, excluding 1,850,603 and 1,682,110 Treasury shares, at December 31, 2018 and 2017, respectively	34,578	32,305
Additional paid-in capital	162,723,051	158,181,192
Retained earnings	17,788,203	1,734,531
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	180,545,832	159,948,028
Noncontrolling interest	998,320	4,235,398
Total shareholders' equity	181,544,152	164,183,426
Total liabilities, mezzanine equity and shareholders' equity	512,999,049	490,635,793
Series A Preferred Stock [Member]
Shareholders' equity
Preferred Stock Value	0	0
Series B Preferred Stock [Member]
Shareholders' equity
Preferred Stock Value	$ 0	$ 0